FI954016A0 - Uudet yhdisteet - Google Patents
Uudet yhdisteetInfo
- Publication number
- FI954016A0 FI954016A0 FI954016A FI954016A FI954016A0 FI 954016 A0 FI954016 A0 FI 954016A0 FI 954016 A FI954016 A FI 954016A FI 954016 A FI954016 A FI 954016A FI 954016 A0 FI954016 A0 FI 954016A0
- Authority
- FI
- Finland
- Prior art keywords
- pct
- alkyl
- date
- fluoroalkyl
- cyano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/59—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/68—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C229/70—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9300657A SE9300657D0 (sv) | 1993-02-26 | 1993-02-26 | New compounds |
PCT/SE1994/000152 WO1994019315A1 (en) | 1993-02-26 | 1994-02-24 | New compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
FI954016A FI954016A (fi) | 1995-08-25 |
FI954016A0 true FI954016A0 (fi) | 1995-08-25 |
Family
ID=20389053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954016A FI954016A0 (fi) | 1993-02-26 | 1995-08-25 | Uudet yhdisteet |
Country Status (16)
Country | Link |
---|---|
US (2) | US5661183A (fi) |
EP (1) | EP0686144B1 (fi) |
JP (1) | JPH08507294A (fi) |
CN (1) | CN1121344A (fi) |
AT (1) | ATE191908T1 (fi) |
AU (1) | AU6159994A (fi) |
CZ (1) | CZ213995A3 (fi) |
DE (1) | DE69424039D1 (fi) |
FI (1) | FI954016A0 (fi) |
HU (1) | HUT72992A (fi) |
IS (1) | IS4133A (fi) |
NO (1) | NO953332D0 (fi) |
PL (1) | PL310398A1 (fi) |
SE (1) | SE9300657D0 (fi) |
SK (1) | SK96995A3 (fi) |
WO (1) | WO1994019315A1 (fi) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2509413C (en) | 2002-12-20 | 2012-05-01 | Glaxo Group Limited | Benzazepine derivatives for the treatment of neurological disorders |
TWI417095B (zh) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途 |
TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
UA100126C2 (en) | 2007-09-14 | 2012-11-26 | Аддекс Фарма С.А. | 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones |
WO2010011871A2 (en) * | 2008-07-23 | 2010-01-28 | The Regents Of The University Of California | Methods and compositions for providing salicylic acid-independent pathogen resistance in plants |
AU2009289784B2 (en) | 2008-09-02 | 2012-03-22 | Addex Pharma S.A. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
BRPI0921333A2 (pt) | 2008-11-28 | 2015-12-29 | Addex Pharmaceuticals Sa | derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
KR101753826B1 (ko) | 2009-05-12 | 2017-07-04 | 얀센 파마슈티칼즈, 인코포레이티드 | 1,2,4―트리아졸로[4,3―a]피리딘 유도체 및 신경정신 질환의 치료 또는 예방을 위한 이들의 용도 |
BRPI1010831A2 (pt) | 2009-05-12 | 2016-04-05 | Addex Pharmaceuticals Sa | derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2 |
AU2011328203B2 (en) | 2010-11-08 | 2015-03-19 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
EP2649069B1 (en) | 2010-11-08 | 2015-08-26 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
ES2536433T3 (es) | 2010-11-08 | 2015-05-25 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
HUE045610T2 (hu) | 2014-01-21 | 2020-01-28 | Janssen Pharmaceutica Nv | 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk |
MX2016009471A (es) | 2014-01-21 | 2016-10-13 | Janssen Pharmaceutica Nv | Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0621083B2 (ja) * | 1986-12-22 | 1994-03-23 | 株式会社三光開発科学研究所 | ジ(アリ−ルオキシ)アルカンの製造方法 |
-
1993
- 1993-02-26 SE SE9300657A patent/SE9300657D0/xx unknown
-
1994
- 1994-02-21 IS IS4133A patent/IS4133A/is unknown
- 1994-02-22 US US08/433,339 patent/US5661183A/en not_active Expired - Lifetime
- 1994-02-22 SK SK969-95A patent/SK96995A3/sk unknown
- 1994-02-22 HU HU9502491A patent/HUT72992A/hu unknown
- 1994-02-22 AU AU61599/94A patent/AU6159994A/en not_active Abandoned
- 1994-02-22 PL PL94310398A patent/PL310398A1/xx unknown
- 1994-02-22 CZ CZ952139A patent/CZ213995A3/cs unknown
- 1994-02-22 JP JP6518900A patent/JPH08507294A/ja active Pending
- 1994-02-22 CN CN94191796A patent/CN1121344A/zh active Pending
- 1994-02-24 WO PCT/SE1994/000152 patent/WO1994019315A1/en active IP Right Grant
- 1994-02-24 DE DE69424039T patent/DE69424039D1/de not_active Expired - Lifetime
- 1994-02-24 EP EP94908556A patent/EP0686144B1/en not_active Expired - Lifetime
- 1994-02-24 AT AT94908556T patent/ATE191908T1/de not_active IP Right Cessation
-
1995
- 1995-08-24 NO NO953332A patent/NO953332D0/no unknown
- 1995-08-25 FI FI954016A patent/FI954016A0/fi unknown
-
1996
- 1996-12-20 US US08/770,488 patent/US5688945A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NO953332L (no) | 1995-08-24 |
DE69424039D1 (de) | 2000-05-25 |
CN1121344A (zh) | 1996-04-24 |
FI954016A (fi) | 1995-08-25 |
EP0686144B1 (en) | 2000-04-19 |
PL310398A1 (en) | 1995-12-11 |
HUT72992A (en) | 1996-06-28 |
HU9502491D0 (en) | 1995-10-30 |
CZ213995A3 (en) | 1996-04-17 |
ATE191908T1 (de) | 2000-05-15 |
EP0686144A1 (en) | 1995-12-13 |
SE9300657D0 (sv) | 1993-02-26 |
US5661183A (en) | 1997-08-26 |
JPH08507294A (ja) | 1996-08-06 |
AU6159994A (en) | 1994-09-14 |
US5688945A (en) | 1997-11-18 |
WO1994019315A1 (en) | 1994-09-01 |
NO953332D0 (no) | 1995-08-24 |
IS4133A (is) | 1994-08-27 |
SK96995A3 (en) | 1996-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI954016A0 (fi) | Uudet yhdisteet | |
DE69305322D1 (de) | Salpetersäureester von 2-(2,6-dihalophenylamino)phenylessigsäurederivaten und verfahren zu ihrer herstellung | |
NO177301C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive N-(aryloksyalkyl)heteroarylpiperidiner og -heteroarylpiperaziner | |
HUP0301249A2 (hu) | APO B termelődés gátló benzamid-vegyületek ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
FI965020A0 (fi) | Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita | |
TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
SE503618C2 (sv) | Antihyperkolesterolemiska tetrazolföreningar | |
HUP0204347A2 (en) | Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them and their use | |
EA200100090A3 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
ATE141606T1 (de) | Cephemverbindungen und verfahren zu ihrer herstellung | |
GB9825554D0 (en) | Novel Compounds | |
PT874841E (pt) | Derivados da 1-benzenossulfonilpirrolidina como antagonistas do receptor da bradiquinina | |
DE69624582D1 (de) | Ester und amide als pla2-inhibitoren | |
SE8501988L (sv) | Iminotiazolidinderivat | |
EP0656355A4 (en) | BIPHENYLMETHANE DERIVATIVE AND MEDICINE CONTAINING THE SAME. | |
ATE189206T1 (de) | Neue verbindungen | |
CA2156079A1 (en) | Novel derivatives of 3-hydroxy anthranilic acid, methods and intermediates for their preparation, novel pharmaceutial compositions and the use thereof | |
PE68299A1 (es) | 1,2,3,4-tetrahidroisoquinolinas terapeuticas | |
TH54292B (th) | กรรมวิธีสำหรับการเตรียม n-แอริล-แอนธรานิลิคแอซิด และอนุพันธ์ของสารเหล่านั้น | |
HUP0203921A2 (hu) | Diazepin-karboxamid-származékok, eljárás a vegyületek előállítására, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |